Home Tags Pharmaceutical Industry

Pharmaceutical Industry Related Content

blood clot risk

Under 40s will be offered an alternative to the Astrazeneca vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.
medicines and vaccines

Countries denied access to vaccines they helped develop

A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
variant vaccines

COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre

Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.
Remdesivir

Combination of remdesivir and hep C drugs effective against COVID-19

A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.
compliance for medical cannabis

Ensuring regulatory compliance for Medical Cannabis

Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
development of vaccines

VMIC: A base for worldwide collaboration in the development of vaccines

We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.
April 2021

Open Access Government April 2021

The April 2021 edition of Open Access Government speaks about government policy issues globally, like COVID-19, health & social care, research & innovation, finance, digital transformation, agriculture, environment and energy.
improving global health

Zebra Technologies: Dedicated to improving global health

We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.
veterinary medicines

Benchmarking Regulatory systems governing veterinary medicines

Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.
falsified medicines

Pharmaceuticals: Falsified medicines

Dr Ash Ramzan, Founder and Principal Consultant, Woodley BioReg Limited, turns the spotlight on falsified medicines in this pharmaceuticals focus.
pharma markets

Why are illegal pharma markets still prevalent today?

Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.
skin care

Cannabidiol, skin homeostasis and acne

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
medicinal cannabis products

The UK’s legalisation of medicinal cannabis

David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
biomedical innovations

Targeted policy support for emerging biomedical innovations

Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
infection prevention and control (IPC)

COVID-19 update: Vaccinations & infection prevention and control (IPC)

Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
COVAX facility

EU allocates additional €500 million to COVAX facility

The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.
heart failure drug

Heart failure drug may treat COVID-19 long-hauler symptom

Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
drug markets

COVID-19 and drugs in the European neighbourhood partnership countries

The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
Medical cannabis in the UK

Medical cannabis in the UK and the industry’s future

Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
virus variants

UK Government and CureVac partnership to tackle COVID-19 virus variants

The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.

Follow Open Access Government